Papain Inhibitor

CAS No. 70195-20-9

Papain Inhibitor( ——— )

Catalog No. M41321 CAS No. 70195-20-9

Papain inhibitor (Glycylglycyl-L-tyrosyl-L-arginine) acts as an effective competitive inhibitor to papain, with a Ki of 9 μM at pH 6.2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 26 In Stock
10MG 46 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Papain Inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    Papain inhibitor (Glycylglycyl-L-tyrosyl-L-arginine) acts as an effective competitive inhibitor to papain, with a Ki of 9 μM at pH 6.2.
  • Description
    Papain inhibitor (Glycylglycyl-L-tyrosyl-L-arginine) acts as an effective competitive inhibitor to papain, with a Ki of 9 μM at pH 6.2.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Papain.
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    70195-20-9
  • Formula Weight
    451.49
  • Molecular Formula
    C19H29N7O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (110.75 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Plumb K, et al. Interaction of a ferrocenoyl-modified peptide with papain: toward protein-sensitive electrochemical probes. Bioconjug Chem. 2003 May-Jun;14(3):601-6.?
molnova catalog
related products
  • GSK2879552 dihydroch...

    GSK2879552 dihydrochloride an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), with potential antineoplastic activity.

  • Moreollic acid

    Moreollic acid has moderate antibacterial activity against methicillin-resistant Staphylococcus aureus with an MIC of 25 microg/ml.

  • N-ε-propargyloxycarb...

    N-ε-propargyloxycarbonyl-L-lysine hydrochloride is a modified amino acid for cancer therapy development.